Literature DB >> 27131860

O-GlcNAcylation is associated with the development and progression of gastric carcinoma.

Tae Jung Jang1, Ui Jung Kim2.   

Abstract

INTRODUCTION: O-GlcNAcylation occurs via an O-linked β-N-acetylglucosamine (O-GlcNAc) moiety linked to the side chain hydroxyl of a serine or threonine residue on nucleocytoplasmic proteins. This reaction, which is catalyzed by O-GlcNAc-transferase (OGT), is involved in a variety of human cancers; however, its clinical significance in gastric carcinomas (GC) has been poorly investigated in vivo.
MATERIALS AND METHODS: Immunohistochemical staining for O-GlcNAcylation and OGT was performed in 64 primary GCs, 40 gastric adenomas and nonneoplastic tissues adjacent to GCs, including 31 tissues of intestinal metaplasia and 24 normal gastric tissues. Their expressions were also studied in 20 tissues of chronic gastritis according to Helicobacter pylori (H. pylori) infection.
RESULTS: O-GlcNAcylation was expressed in the nucleus and both the nuclear rim and cytoplasm. OGT was strongly expressed in the nucleus and weakly expressed in the cytoplasm. O-GlcNAcylation expression levels were significantly correlated with those of OGT. Their expression levels were progressively increased during the carcinogenesis of GC. O-GlcNAcylation expression was higher in GC with intestinal type, higher pT stage and nodal metastasis, while OGT expression was higher in GC with nodal metastasis. Nuclear O-GlcNAcylation expression was more frequently observed in tumors including GC and adenoma than in nonneoplastic tissues including intestinal metaplasia and normal tissue. Nuclear O-GlcNAcylation expression in GC was closely associated with large size, moderate and poor differentiation, higher pT stage, nodal metastasis and higher clinical stage. In addition, the expression of O-GlcNAcylation and OGT was more elevated in H. pylori-infected chronic gastritis than in chronic gastritis without H. pylori infection.
CONCLUSIONS: O-GlcNAcylation expression and its nuclear expression were associated with the carcinogenesis and progression of GC.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Gastric carcinoma; O-GlcNAc-transferase; O-GlcNAcylation

Mesh:

Substances:

Year:  2016        PMID: 27131860     DOI: 10.1016/j.prp.2016.04.002

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

Review 1.  O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.

Authors:  John A Hanover; Weiping Chen; Michelle R Bond
Journal:  J Bioenerg Biomembr       Date:  2018-03-29       Impact factor: 2.945

2.  Non-targeted metabolomics reveals diagnostic biomarker in the tongue coating of patients with chronic gastritis.

Authors:  Xiyan Mu; Chuanyuan Ji; Qi Wang; Kun Liu; Xinyu Hao; Guanhua Zhang; Xiaowei Shi; Yuqian Zhang; Frank J Gonzalez; Qiao Wang; Yangang Wang
Journal:  J Pharm Biomed Anal       Date:  2019-06-20       Impact factor: 3.935

3.  GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.

Authors:  Shimeng Cheng; Qiqi Mao; Yabing Dong; Jie Ren; Lina Su; Jianlan Liu; Qingmei Liu; Jing Zhou; Xiaolu Ye; Shudan Zheng; Ningwen Zhu
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 4.  O-GlcNAcylation and Its Role in Cancer-Associated Inflammation.

Authors:  Muzi Ouyang; Changmeng Yu; Xiaolian Deng; Yingyi Zhang; Xudong Zhang; Fangfang Duan
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 5.  O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.

Authors:  Qingsong Lu; Xiaozhen Zhang; Tingbo Liang; Xueli Bai
Journal:  Mol Med       Date:  2022-09-14       Impact factor: 6.376

6.  Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.

Authors:  Mingzuo Jiang; Zhaoyan Qiu; Song Zhang; Xing Fan; Xiqiang Cai; Bing Xu; Xiaowei Li; Jinfeng Zhou; Xiangyuan Zhang; Yi Chu; Weijie Wang; Jie Liang; Tamas Horvath; Xiaoyong Yang; Kaichun Wu; Yongzhan Nie; Daiming Fan
Journal:  Oncotarget       Date:  2016-09-20

7.  O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.

Authors:  Nan Wu; Mingzuo Jiang; Yuying Han; Haiming Liu; Yi Chu; Hao Liu; Jiayi Cao; Qiuqiu Hou; Yu Zhao; Bing Xu; Xin Xie
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

Review 8.  Functional Analysis of O-GlcNAcylation in Cancer Metastasis.

Authors:  Donglu Wu; Jingji Jin; Zhidong Qiu; Da Liu; Haoming Luo
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.